Kazuo Komamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kazuo Komamura has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Kunio Miyatake
From the Research Institute (K.Komamura, R.T., Y.S., K.Kangawa); Division of Cardiology (K.Komamura, H.T., M.K., K.Miyatake), National Cardiovascular Center; Kyoto Institute of Technology (J.M., K.Matsumoto, E.Y., T.Nakamura), Osaka University, Graduate School of Medicine; Department of Cardiovascular Surgery (T.Nakatani, S.K.), National Cardiovascular Center, Suita, Japan
3 shared publicationsRie Tatsumi
Department of Cardiovascular Dynamics, Research Institute, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai,Suita, Osaka 565-8565, Japan
3 shared publicationsHitonobu Tomoike
From the Research Institute (K.Komamura, R.T., Y.S., K.Kangawa); Division of Cardiology (K.Komamura, H.T., M.K., K.Miyatake), National Cardiovascular Center; Kyoto Institute of Technology (J.M., K.Matsumoto, E.Y., T.Nakamura), Osaka University, Graduate School of Medicine; Department of Cardiovascular Surgery (T.Nakatani, S.K.), National Cardiovascular Center, Suita, Japan
2 shared publicationsJ. Kawai
Applied Electronics Laboratory, Kanazawa Institute of Technology, 3 Amaike-cho, Kanazawa, 920-1331 Japan
2 shared publicationsM. Miyamoto
Applied Electronics Laboratory, Kanazawa Institute of Technology, 3 Amaike-cho, Kanazawa, 920-1331 Japan
2 shared publicationsMasafumi Kitakaze
Department of Cardiology, National Cardiovascular Center, Suita, Japan
2 shared publications
Latest Publications
- Open Access
- 9 December 2010
- Published by Wiley in Journal of Drug Delivery
- Vol. 2011, 1-8
Cellular Injury of Cardiomyocytes during Hepatocyte Growth Factor Gene Transfection with Ultrasound-Triggered Bubble Liposome Destruction
We transfected naked HGF plasmid DNA into cultured cardiomyocytes using a sonoporation method consisting of ultrasound-triggered bubble liposome destruction. We examined the effects on transfection efficiency of three concentrations of bubble liposome (, , /mL), three concentrations of HGF DNA (60, 120, 180 μg/mL), two insonification times (30, 60 sec), and three incubation times (15, 60, 120 min). We found that low concentrations of bubble liposome and low concentrations of DNA provided the largest amount of the HGF protein expression by the sonoporated cardiomyocytes. Variation of insonification and incubation times did not affect the amount of product. Following insonification, cardiomyocytes showed cellular injury, as determined by a dye exclusion test. The extent of injury was most severe with the highest concentration of bubble liposome. In conclusion, there are some trade-offs between gene transfection efficiency and cellular injury using ultrasound-triggered bubble liposome destruction as a method for gene transfection.- 9 December 2010
- Published by Wiley in Journal of Drug Delivery
- Vol. 2011, 1-8
Open AccessCellular Injury of Cardiomyocytes during Hepatocyte Growth Factor Gene Transfection with Ultrasound-Triggered Bubble Liposome Destruction
We transfected naked HGF plasmid DNA into cultured cardiomyocytes using a sonoporation method consisting of ultrasound-triggered bubble liposome destruction. We examined the effects on transfection efficiency of three concentrations of bubble liposome (, , /mL), three concentrations of HGF DNA (60, 120, 180 μg/mL), two insonification times (30, 60 sec), and three incubation times (15, 60, 120 min). We found that low concentrations of bubble liposome and low concentrations of DNA provided the largest amount of the HGF protein expression by the sonoporated cardiomyocytes. Variation of insonification and incubation times did not affect the amount of product. Following insonification, cardiomyocytes showed cellular injury, as determined by a dye exclusion test. The extent of injury was most severe with the highest concentration of bubble liposome. In conclusion, there are some trade-offs between gene transfection efficiency and cellular injury using ultrasound-triggered bubble liposome destruction as a method for gene transfection. - 1 August 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 33-35
Micro-Magnetocardiography System with a Single-Chip SQUID Magnetometer Array for QT Analysis and Diagnosis of Myocardial Injury in Small Animals
Development of drugs needs electrophysiological studies of small animals like mice, rats or guinea pigs. Electrocardiography (ECG) of hirsute animals is time-consuming. We have developed a micro magnetometer array with 9-channel superconducting quantum interference device (SQUID) with 2.5-mm diameter pickup-coil for non-contact measurement of magnetocardiogram (MCG) in small animals. The micro-MCG successfully recorded PQRST complex in mice, rats and guinea pigs. Regional myocardial injury was made with cryoinjury probe in rat hearts, and the injured pattern in MCG was recorded. Anterior myocardial injury created QS pattern in MCG, and posterior myocardial injury created QR pattern in MCG. Quinidine-induced QT prolongation was successfully detected by micro MCG in mice and rats. Simultaneous recording of ECG and MCG after intraperitoneal administration of quinidine (60 mg/kg) in guinea pigs. Both QTc in ECG and MCG correlated well. Newly developed micro MCG may facilitate the research process of electrophysiological studies of small animals, and may enable high throughput screening of drug-induced QT abnormality.
- 1 August 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 33-35
Micro-Magnetocardiography System with a Single-Chip SQUID Magnetometer Array for QT Analysis and Diagnosis of Myocardial Injury in Small Animals
Development of drugs needs electrophysiological studies of small animals like mice, rats or guinea pigs. Electrocardiography (ECG) of hirsute animals is time-consuming. We have developed a micro magnetometer array with 9-channel superconducting quantum interference device (SQUID) with 2.5-mm diameter pickup-coil for non-contact measurement of magnetocardiogram (MCG) in small animals. The micro-MCG successfully recorded PQRST complex in mice, rats and guinea pigs. Regional myocardial injury was made with cryoinjury probe in rat hearts, and the injured pattern in MCG was recorded. Anterior myocardial injury created QS pattern in MCG, and posterior myocardial injury created QR pattern in MCG. Quinidine-induced QT prolongation was successfully detected by micro MCG in mice and rats. Simultaneous recording of ECG and MCG after intraperitoneal administration of quinidine (60 mg/kg) in guinea pigs. Both QTc in ECG and MCG correlated well. Newly developed micro MCG may facilitate the research process of electrophysiological studies of small animals, and may enable high throughput screening of drug-induced QT abnormality.
- 30 June 2007
- Published by Elsevier in International Congress Series
- Vol. 1300, 574-577
Diagnosis of the location of myocardial injury using mouse/rat magnetocardiography system with a single-chip SQUID magnetometer array
- 30 June 2007
- Published by Elsevier in International Congress Series
- Vol. 1300, 574-577
Diagnosis of the location of myocardial injury using mouse/rat magnetocardiography system with a single-chip SQUID magnetometer array
Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy
Objective: To determine whether concentrations of heart-type fatty acid binding protein (H-FABP) measured before hospital discharge predict critical cardiac events in patients with idiopathic dilated cardiomyopathy (DCM). Patients: 92 consecutive patients with DCM were enrolled and followed up for four years. Main outcome measures: Serum concentrations of H-FABP, brain natriuretic peptide (BNP), cardiac troponin T before hospital discharge and survival rate. Results: 23 patients died of cardiac causes, received a left ventricular assist device or underwent heart transplantation during the four-year follow up. Univariate analyses showed that New York Heart Association functional class, heart rate, ejection fraction, serum H-FABP and plasma BNP were significant variables. According to multivariate analysis, serum H-FABP and plasma BNP concentrations were independent predictors of critical cardiac events. Cardiac troponin T before hospital discharge was not a predictor. The area under the receiver operating characteristic curve for death from critical cardiac events was similar between H-FABP and BNP. Patients with an H-FABP concentration at or above the median (⩾ 5.4 ng/ml) had a significantly lower survival rate than those below the median, according to analysis by log rank test (p < 0.0001). When combined with BNP concentration at or above the median (⩾ 138 pg/ml), H-FABP below the median predicted the worst prognosis among the combinations. Conclusions: The concentration of serum H-FABP before discharge from hospital may be an independent predictor for critical cardiac events in DCM.
Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy
Objective: To determine whether concentrations of heart-type fatty acid binding protein (H-FABP) measured before hospital discharge predict critical cardiac events in patients with idiopathic dilated cardiomyopathy (DCM). Patients: 92 consecutive patients with DCM were enrolled and followed up for four years. Main outcome measures: Serum concentrations of H-FABP, brain natriuretic peptide (BNP), cardiac troponin T before hospital discharge and survival rate. Results: 23 patients died of cardiac causes, received a left ventricular assist device or underwent heart transplantation during the four-year follow up. Univariate analyses showed that New York Heart Association functional class, heart rate, ejection fraction, serum H-FABP and plasma BNP were significant variables. According to multivariate analysis, serum H-FABP and plasma BNP concentrations were independent predictors of critical cardiac events. Cardiac troponin T before hospital discharge was not a predictor. The area under the receiver operating characteristic curve for death from critical cardiac events was similar between H-FABP and BNP. Patients with an H-FABP concentration at or above the median (⩾ 5.4 ng/ml) had a significantly lower survival rate than those below the median, according to analysis by log rank test (p < 0.0001). When combined with BNP concentration at or above the median (⩾ 138 pg/ml), H-FABP below the median predicted the worst prognosis among the combinations. Conclusions: The concentration of serum H-FABP before discharge from hospital may be an independent predictor for critical cardiac events in DCM.
- 1 September 2004
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (3) , 365-371
Treatment of Dilated Cardiomyopathy With Electroporation of Hepatocyte Growth Factor Gene Into Skeletal Muscle
Hepatocyte growth factor (HGF) is a potent angiogenic and antifibrotic factor. Cardioprotective effects of HGF for idiopathic dilated cardiomyopathy were examined in hamsters with electroporation of plasmid DNA into skeletal muscle. We used hamster skeletal muscle as a protein producer of HGF gene. A plasmid vector encoding HGF (HGF group, n=12) or empty plasmid (placebo group, n=12) was transferred with in vivo electroporation into tibialis anterior muscles of hamsters with inherited dilated cardiomyopathy (TO-2 strain). The HGF group had greater serum HGF levels (21.6±2.2 versus 0.11±0.07 ng/mL, P P P P P 2 , P P <0.05) than did the placebo group. Exogenous HGF might improve the deleterious changes in myocardial function and structure in the hamster with dilated cardiomyopathy. Systemic delivery of gene products with in vivo electroporation into skeletal muscle seemed to be an alternative means of direct gene delivery.
- 1 September 2004
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (3) , 365-371
Treatment of Dilated Cardiomyopathy With Electroporation of Hepatocyte Growth Factor Gene Into Skeletal Muscle
Hepatocyte growth factor (HGF) is a potent angiogenic and antifibrotic factor. Cardioprotective effects of HGF for idiopathic dilated cardiomyopathy were examined in hamsters with electroporation of plasmid DNA into skeletal muscle. We used hamster skeletal muscle as a protein producer of HGF gene. A plasmid vector encoding HGF (HGF group, n=12) or empty plasmid (placebo group, n=12) was transferred with in vivo electroporation into tibialis anterior muscles of hamsters with inherited dilated cardiomyopathy (TO-2 strain). The HGF group had greater serum HGF levels (21.6±2.2 versus 0.11±0.07 ng/mL, P P P P P 2 , P P <0.05) than did the placebo group. Exogenous HGF might improve the deleterious changes in myocardial function and structure in the hamster with dilated cardiomyopathy. Systemic delivery of gene products with in vivo electroporation into skeletal muscle seemed to be an alternative means of direct gene delivery.
- Open Access
Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A
A 35 year old man was diagnosed as having Fabry disease because of extremely low activity of α-galactosidase A and a point mutation of its gene. He had been suffering from acroparesthesias, angiokeratoma, corneal opacity, and hypohidrosis. Since his neuropathic pain was resistant to conventional treatment, he agreed with written informed …
Open AccessImprovement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant α-galactosidase A
A 35 year old man was diagnosed as having Fabry disease because of extremely low activity of α-galactosidase A and a point mutation of its gene. He had been suffering from acroparesthesias, angiokeratoma, corneal opacity, and hypohidrosis. Since his neuropathic pain was resistant to conventional treatment, he agreed with written informed …
- Open Access
- 24 February 2004
- Published by Springer Nature in Journal of Human Genetics
- Vol. 49 (3) , 129-133
The role of a common TNNT2 polymorphism in cardiac hypertrophy
We found a five-basepair insertion/deletion polymorphism in intron 3 of TNNT2, one of the genes responsible for hypertrophic cardiomyopathy. These five bases may be part of an intronic polypyrimidine tract sequence that may affect splicing. The purpose of the study was to examine the association of the polymorphism with cardiac hypertrophy. The study population consisted of 151 subjects with prominent concentric left ventricular hypertrophy, and 987 healthy subjects recruited from medical checkups (control population). The deletion/deletion genotype tended to be associated with a larger left ventricular mass/height ratio in the HCM population (ppR=0.738) by the TNNT2 genotype. Moreover, the frequency of the deletion allele was significantly higher in the hypertrophy population than in the control population (pTNNT2 deletion allele could be associated with a predisposition to prominent left ventricular hypertrophy.
- 24 February 2004
- Published by Springer Nature in Journal of Human Genetics
- Vol. 49 (3) , 129-133
Open AccessThe role of a common TNNT2 polymorphism in cardiac hypertrophy
We found a five-basepair insertion/deletion polymorphism in intron 3 of TNNT2, one of the genes responsible for hypertrophic cardiomyopathy. These five bases may be part of an intronic polypyrimidine tract sequence that may affect splicing. The purpose of the study was to examine the association of the polymorphism with cardiac hypertrophy. The study population consisted of 151 subjects with prominent concentric left ventricular hypertrophy, and 987 healthy subjects recruited from medical checkups (control population). The deletion/deletion genotype tended to be associated with a larger left ventricular mass/height ratio in the HCM population (ppR=0.738) by the TNNT2 genotype. Moreover, the frequency of the deletion allele was significantly higher in the hypertrophy population than in the control population (pTNNT2 deletion allele could be associated with a predisposition to prominent left ventricular hypertrophy.
- 1 July 2003
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 17 (4) , 303-310
Differential Gene Expression in the Rat Skeletal and Heart Muscle in Glucocorticoid-Induced Myopathy: Analysis by Microarray
Administration of glucocorticoids results in hypertension, cardiac hypertrophy, and general myopathy. The present study analyzed the acute effect of dexamethasone (0.5 mg/100 g for 3 days) or...
- 1 July 2003
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 17 (4) , 303-310
Differential Gene Expression in the Rat Skeletal and Heart Muscle in Glucocorticoid-Induced Myopathy: Analysis by Microarray
Administration of glucocorticoids results in hypertension, cardiac hypertrophy, and general myopathy. The present study analyzed the acute effect of dexamethasone (0.5 mg/100 g for 3 days) or...
- Open Access
Transthoracic Doppler flow images detect cardiac angiosarcoma earlier than other imaging modalities